Investigative Ophthalmology & Visual Science Cover Image for Volume 61, Issue 7
June 2020
Volume 61, Issue 7
Free
ARVO Annual Meeting Abstract  |   June 2020
β zone Peripapillary Atrophy as a Predictor of Glaucomatous Structural and Functional Progression
Author Affiliations & Notes
  • Alexi Geevarghese
    Department of Ophthalmology, NYU Langone Health, New York, New York, United States
  • Fabio Lavinsky
    Department of Ophthalmology, NYU Langone Health, New York, New York, United States
  • Hiroshi Ishikawa
    Department of Ophthalmology, NYU Langone Health, New York, New York, United States
  • Mengfei Wu
    Department of Ophthalmology, NYU Langone Health, New York, New York, United States
  • Mengling Liu
    Department of Ophthalmology, NYU Langone Health, New York, New York, United States
  • Jenna Tauber
    Department of Ophthalmology, NYU Langone Health, New York, New York, United States
  • Joseph Panarelli
    Department of Ophthalmology, NYU Langone Health, New York, New York, United States
  • Assumpta A. Madu
    Department of Ophthalmology, NYU Langone Health, New York, New York, United States
  • Joel S Schuman
    Department of Ophthalmology, NYU Langone Health, New York, New York, United States
  • Gadi Wollstein
    Department of Ophthalmology, NYU Langone Health, New York, New York, United States
  • Footnotes
    Commercial Relationships   Alexi Geevarghese, None; Fabio Lavinsky, None; Hiroshi Ishikawa, None; Mengfei Wu, None; Mengling Liu, None; Jenna Tauber, None; Joseph Panarelli, None; Assumpta Madu, None; Joel Schuman, Zeiss (P); Gadi Wollstein, None
  • Footnotes
    Support  NIH: R01-EY013178 and an unrestricted grant by the Research to Prevent Blindness
Investigative Ophthalmology & Visual Science June 2020, Vol.61, 3211. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Alexi Geevarghese, Fabio Lavinsky, Hiroshi Ishikawa, Mengfei Wu, Mengling Liu, Jenna Tauber, Joseph Panarelli, Assumpta A. Madu, Joel S Schuman, Gadi Wollstein; β zone Peripapillary Atrophy as a Predictor of Glaucomatous Structural and Functional Progression. Invest. Ophthalmol. Vis. Sci. 2020;61(7):3211.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : The presence of β zone peripapillary atrophy (PPA) has been associated with glaucoma. We performed a retrospective longitudinal study to evaluate β zone PPA area as a predictor for glaucomatous structural and functional progression.

Methods : Subjects with glaucoma and ≥4 visits were included. Subjects had Humphrey visual field (Zeiss, Dublin, CA) testing, spectral-domain OCT (Cirrus HD-OCT; Zeiss) optic nerve head (ONH) and macula scans. β zone PPA was manually delineated on the baseline en face ONH scan as the area contiguous with the optic disc with the presence of hyper- and hyporeflectivity. Mixed effects linear models accounting for intra-subject correlation, follow-up time, scan’s signal strength and ethnicity, were performed to determine if baseline PPA area was associated with glaucoma severity. Subsequent models incorporating the interaction term between time and baseline PPA area were performed to determine if baseline PPA area affected the rate of change in parameters of glaucoma over time.

Results : 81 eyes (56 subjects) aged 62.8±14.1 years with an average follow-up time 3.9±1.3 years were analyzed. PPA was significantly associated with mean deviation (MD), visual field index (VFI), and inferior retinal nerve fiber layer (RNFL), (p=0.033, 0.038, and 0.034, respectively), but not with average RNFL, or macular ganglion cell inner plexiform layer (GCIPL) global and sectoral measurements and ONH parameters. No significant association was detected between β zone PPA area and the rate of progression for any parameter except for VFI (p =0.035).

Conclusions : Although baseline β zone PPA area is associated with some indicators of glaucoma severity, it is not a significant predictor of the rate of glaucomatous progression (except for VFI).

This is a 2020 ARVO Annual Meeting abstract.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×